In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Zenas Biopharma Inc (NASDAQ: ZBIO) closed the day trading at $12.00 up 14.94% from the previous closing price of $10.44. In other words, the price has increased by $14.94 from its previous closing price. On the day, 0.79 million shares were traded. ZBIO stock price reached its highest trading level at $12.365 during the session, while it also had its lowest trading level at $9.545.
Ratios:
For a better understanding of ZBIO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.95 and its Current Ratio is at 8.95. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 05, 2024, initiated with a Buy rating and assigned the stock a target price of $34.
On October 08, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $40.
On October 08, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $35.Jefferies initiated its Buy rating on October 08, 2024, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 ’24 when MOULDER LEON O JR bought 7,500 shares for $15.00 per share. The transaction valued at 112,500 led to the insider holds 168,655 shares of the business.
MOULDER LEON O JR bought 2,500 shares of ZBIO for $36,425 on Nov 19 ’24. The Chief Executive Officer now owns 171,155 shares after completing the transaction at $14.57 per share. On Sep 18 ’24, another insider, MOULDER LEON O JR, who serves as the Chief Executive Officer of the company, bought 10,000 shares for $17.91 each. As a result, the insider paid 179,100 and bolstered with 1,662,039 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZBIO now has a Market Capitalization of 501492000.
Stock Price History:
Over the past 52 weeks, ZBIO has reached a high of $26.25, while it has fallen to a 52-week low of $10.05. The 50-Day Moving Average of the stock is -36.60%, while the 200-Day Moving Average is calculated to be -36.55%.
Shares Statistics:
Over the past 3-months, ZBIO traded about 187.01K shares per day on average, while over the past 10 days, ZBIO traded about 253670 shares per day. A total of 38.32M shares are outstanding, with a floating share count of 9.86M. Shares short for ZBIO as of 1730332800 were 635745 with a Short Ratio of 3.40, compared to 1727654400 on 230551.
